134 related articles for article (PubMed ID: 23612541)
1. Increased circulating advanced glycation endproducts (AGEs) in acute trauma patients.
Schulman CI; Uribarri J; Cai W; Manning R; Landy DC; Gallardo M; Castillo A; Namias N; Striker GE; Livingstone A; Vlassara H
Clin Chem Lab Med; 2014 Jan; 52(1):103-8. PubMed ID: 23612541
[TBL] [Abstract][Full Text] [Related]
2. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
[TBL] [Abstract][Full Text] [Related]
3. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
[TBL] [Abstract][Full Text] [Related]
4. Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
de la Cruz-Ares S; Cardelo MP; Gutiérrez-Mariscal FM; Torres-Peña JD; García-Rios A; Katsiki N; Malagón MM; López-Miranda J; Pérez-Martínez P; Yubero-Serrano EM
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963378
[TBL] [Abstract][Full Text] [Related]
5. Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
Yubero-Serrano EM; Woodward M; Poretsky L; Vlassara H; Striker GE;
Clin J Am Soc Nephrol; 2015 May; 10(5):759-66. PubMed ID: 25710801
[TBL] [Abstract][Full Text] [Related]
6. Dietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patients.
Uribarri J; Peppa M; Cai W; Goldberg T; Lu M; Baliga S; Vassalotti JA; Vlassara H
Am J Kidney Dis; 2003 Sep; 42(3):532-8. PubMed ID: 12955681
[TBL] [Abstract][Full Text] [Related]
7. The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Barzilay JI; Jablonski KA; Fonseca V; Shoelson SE; Goldfine AB; Strauch C; Monnier VM;
Diabetes Care; 2014 Apr; 37(4):1083-91. PubMed ID: 24255104
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
[TBL] [Abstract][Full Text] [Related]
9. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
10. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
[TBL] [Abstract][Full Text] [Related]
11. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.
Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG
PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493
[TBL] [Abstract][Full Text] [Related]
12. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
Semba RD; Gebauer SK; Baer DJ; Sun K; Turner R; Silber HA; Talegawkar S; Ferrucci L; Novotny JA
J Nutr; 2014 Jul; 144(7):1037-42. PubMed ID: 24744309
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Taurine Supplementation on Metabolic Profiles, Pentosidine, Soluble Receptor of Advanced Glycation End Products and Methylglyoxal in Adults With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Esmaeili F; Maleki V; Kheirouri S; Alizadeh M
Can J Diabetes; 2021 Feb; 45(1):39-46. PubMed ID: 32861603
[TBL] [Abstract][Full Text] [Related]
14. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
[No Abstract] [Full Text] [Related]
15. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
[TBL] [Abstract][Full Text] [Related]
16. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.
Galler A; Müller G; Schinzel R; Kratzsch J; Kiess W; Münch G
Diabetes Care; 2003 Sep; 26(9):2609-15. PubMed ID: 12941727
[TBL] [Abstract][Full Text] [Related]
17. Circulating Advanced Glycation Endproducts and Long-Term Risk of Cardiovascular Mortality in Kidney Transplant Recipients.
Sotomayor CG; Gomes-Neto AW; van Londen M; Gans ROB; Nolte IM; Berger SP; Navis GJ; Rodrigo R; Leuvenink HGD; Schalkwijk CG; Bakker SJL
Clin J Am Soc Nephrol; 2019 Oct; 14(10):1512-1520. PubMed ID: 31530552
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.
Semba RD; Ferrucci L; Sun K; Beck J; Dalal M; Varadhan R; Walston J; Guralnik JM; Fried LP
Aging Clin Exp Res; 2009 Apr; 21(2):182-90. PubMed ID: 19448391
[TBL] [Abstract][Full Text] [Related]
19. Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.
Sebeková K; Kupcová V; Schinzel R; Heidland A
J Hepatol; 2002 Jan; 36(1):66-71. PubMed ID: 11804666
[TBL] [Abstract][Full Text] [Related]
20. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.
de Courten B; de Courten MP; Soldatos G; Dougherty SL; Straznicky N; Schlaich M; Sourris KC; Chand V; Scheijen JL; Kingwell BA; Cooper ME; Schalkwijk CG; Walker KZ; Forbes JM
Am J Clin Nutr; 2016 Jun; 103(6):1426-33. PubMed ID: 27030534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
